atorvastatin has been researched along with Angiogenesis, Pathologic in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 12 (66.67) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Baganha, F; de Jong, RCM; de Vries, MR; Delibegovic, M; Jukema, JW; Peters, EA; Quax, PHA; Voorham, W | 1 |
| Ayen, E; Bahrami, A; Behfar, M; Razi, M | 1 |
| Liu, HY; Tang, Y; Tong, H; Wang, XF; Zhou, J; Zhou, QC | 1 |
| Camsari, UM; Ekerbicer, N; Gurpinar, T; Guvendi, G; Sisman, AR; Uysal, N | 1 |
| Ai, A; Ai, J; Bayat, N; Ebrahimi-Barough, S; Izadpanah, R; Mokhtari Ardakan, MM; Norouzi Javidan, A; Saberi, H | 1 |
| Bai, QK; Deng, SH; Jiang, Q; Jiang, XZ; Zhang, Y; Zhang, ZP; Zhu, YC | 1 |
| Bianchi, C; Chu, LM; Dalal, RS; Elmadhun, NY; Sabe, AA; Sadek, AA; Sellke, FW | 1 |
| Cheng, WL; Chiang, KH; Huang, CY; Kao, YT; Lin, CT; Lin, FY; Lin, YW; Shih, CM; Tsao, NW; Wu, SC | 1 |
| Arbustini, E; Gambarin, FI | 1 |
| Caruthers, SD; Lanza, GM; Wickline, SA; Williams, TA; Winter, PM; Zhang, H | 1 |
| Blann, AD; Goon, PK; Jaumdally, RJ; Lip, GY; Varma, C | 1 |
| Andrade, SP; Araújo, FA; Mendes, JB; Rocha, MA | 1 |
| Biessen, EA; Bot, I; Jukema, JW; Lankhuizen, IM; van Berkel, TJ | 1 |
| Aebi, JD; Chapuis-Bernasconi, C; Dehmlow, H; Fischer, H; Juillerat-Jeanneret, L; Staedler, D | 1 |
| Chen, J; Jiang, R; Li, Z; Sun, L; Tian, Y; Wang, B; Wang, D; Wei, H; Yang, Z; Zhang, J | 1 |
| Andalib, S; Asadpoor, M; Doustar, Y; Garjani, A; Garjani, M; Khorrami, A; Maleki-Dizaji, N; Rezazadeh, H; Soraya, H; Ziaee, M | 1 |
| Karas, RH; Kimmelstiel, C; Pourati, I; Rand, W | 1 |
| Cooke, JP; Glassford, AJ; Heeschen, C; Weis, M | 1 |
1 trial(s) available for atorvastatin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Evaluating the Efficacy of Atorvastatin on Patients with Carotid Plaque by an Innovative Ultrasonography.
Topics: Aged; Aged, 80 and over; Atorvastatin; Biomarkers; Carotid Arteries; Carotid Artery Diseases; China; Cholesterol, LDL; Contrast Media; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neovascularization, Pathologic; Phospholipids; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Sulfur Hexafluoride; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Color | 2019 |
17 other study(ies) available for atorvastatin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization.
Topics: Angiopoietin-2; Animals; Antigens, CD; Apolipoprotein E3; Atorvastatin; Cadherins; Cholesterol, Dietary; Male; Mice; Mice, Mutant Strains; Neovascularization, Pathologic; Plaque, Atherosclerotic | 2021 |
Effects of atorvastatin and resveratrol against the experimental endometriosis; evidence for glucose and monocarboxylate transporters, neoangiogenesis.
Topics: Animals; Atorvastatin; Endometriosis; Excitatory Amino Acid Transporter 2; Female; Glucose; Glucose Transporter Type 3; Glycolysis; Monocarboxylic Acid Transporters; Muscle Proteins; Neovascularization, Pathologic; Rats; Rats, Wistar; Resveratrol; Symporters | 2021 |
Quantitative evaluation of atherosclerotic plaques and intraplaque neovascularization using contrast-enhanced ultrasound after treatment with atorvastatin in rabbits.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Contrast Media; Neovascularization, Pathologic; Plaque, Atherosclerotic; Rabbits; Ultrasonography | 2017 |
Statins reduce testicular and ocular VEGF: A potential compromise to microcirculation.
Topics: Angiogenesis Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Eye; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microcirculation; Neovascularization, Pathologic; Rats, Wistar; Testis; Vascular Endothelial Growth Factor A | 2018 |
The Anti-Angiogenic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel: in 3D in Vitro Model
Topics: Angiogenesis Inhibitors; Anticholesteremic Agents; Atorvastatin; Cell Culture Techniques; Cell Movement; Cells, Cultured; Fibrin; Gels; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Neovascularization, Pathologic; Spheroids, Cellular | 2018 |
Atorvastatin regulates apoptosis in chronically ischemic myocardium.
Topics: Animals; Apoptosis; Atorvastatin; bcl-2-Associated X Protein; Caspase 3; Chronic Disease; Disease Models, Animal; Gene Expression Regulation, Developmental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MAP Kinase Signaling System; Metabolic Syndrome; Myocardial Ischemia; Myocardium; Neovascularization, Pathologic; Pyrroles; Swine; Swine, Miniature | 2015 |
Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
Topics: Animals; Atorvastatin; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Electron Spin Resonance Spectroscopy; Endothelial Progenitor Cells; Flow Cytometry; Hindlimb; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Ischemia; Male; Mice; Mice, Inbred ICR; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosuvastatin Calcium; Signal Transduction | 2015 |
Theranostic strategy against plaque angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Atherosclerosis; Atorvastatin; Carbocyanines; Cyclohexanes; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Unsaturated; Heptanoic Acids; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Pyrroles; Sesquiterpenes; Time Factors | 2008 |
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
Topics: Angiogenesis Inhibitors; Animals; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Carbocyanines; Cyclohexanes; Disease Models, Animal; Drug Carriers; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Unsaturated; Heptanoic Acids; Heterocyclic Compounds, 1-Ring; Integrin alphaVbeta3; Liver; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Pyrroles; Rabbits; Sesquiterpenes; Time Factors | 2008 |
Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
Topics: Aged; Angiopoietin-1; Angiopoietin-2; Antigens, CD; Antigens, CD34; Atherosclerosis; Atorvastatin; Diabetes Mellitus; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocyte Common Antigens; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Pyrroles; Stem Cells; Vascular Endothelial Growth Factor A | 2010 |
Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1.
Topics: Administration, Oral; Animals; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Male; Mice; Neovascularization, Pathologic; Pyrroles; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2010 |
Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels.
Topics: Angiogenesis Inhibitors; Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Cell Line; Cell Proliferation; Cholesterol; Connective Tissue; Disease Models, Animal; Endothelial Cells; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Knockout; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Pyrroles; Time Factors | 2011 |
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
Topics: Alkynes; Angiogenesis Inhibitors; Animals; Anticholesteremic Agents; Antineoplastic Agents; Atorvastatin; Brain; Carbamates; Cell Line, Tumor; Cell Proliferation; Cricetinae; Cyclohexanes; Drug Screening Assays, Antitumor; Drug Synergism; Endothelial Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intramolecular Transferases; Microsomes, Liver; Neovascularization, Pathologic; Pyrroles; Structure-Activity Relationship | 2012 |
Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats.
Topics: Animals; Atorvastatin; Brain Injuries; Endothelial Cells; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Long-Term Potentiation; Male; Maze Learning; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Wistar; Recovery of Function; Stem Cells | 2012 |
Ambivalent effects of atorvastatin on angiogenesis, epidermal cell proliferation and tumorgenesis in animal models.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Atorvastatin; Cell Proliferation; Croton Oil; Epidermal Cells; Epidermis; Female; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mevalonic Acid; Mice; Neovascularization, Pathologic; Pyrroles; Rats; Rats, Wistar; Skin Neoplasms | 2012 |
Statin use is associated with enhanced collateralization of severely diseased coronary arteries.
Topics: Aged; Aspirin; Atorvastatin; Calcium Channels; Collateral Circulation; Coronary Angiography; Coronary Disease; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Neovascularization, Pathologic; Pyrroles; Retrospective Studies | 2003 |
Statins have biphasic effects on angiogenesis.
Topics: Animals; Apolipoproteins E; Apoptosis; Atorvastatin; Carcinoma, Lewis Lung; Cell Differentiation; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lymphokines; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neovascularization, Physiologic; Polyisoprenyl Phosphates; Pyridines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |